Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy
This study has been completed.
Study NCT00663949 Information provided by Shiraz University of Medical Sciences
First Received: April 21, 2008 No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Nephropathy
Additional conditions recognized in this trial
Diabetic Nephropathies
Kidney Diseases
Proteinuria
More general conditions related to this trial
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
Captopril
Captopril + Pentoxifylline
Additional drug interventions recognized in this trial
Pentoxifylline
More general drug interventions related to this trial
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Antioxidants
Cardiovascular Agents
Enzyme Inhibitors
Free Radical Scavengers
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Protease Inhibitors
Protective Agents
Radiation-Protective Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Shiraz University of Medical Sciences
Back to top of Main Content
